Skip to main content

Practical Updates in Lymphoma

This item is expired.



Evaluated by: 
David B. Kaminsky, M.D., FIAC, April 11, 2018
Original release date: May 23, 2018
Access to this course expires on:  April 11, 2021, at 11:59 PM Pacific Time
CME 15.5

Course Description
Lymphomas are highly heterogeneous, consisting of numerous clinicopathologic subtypes and variants whose diagnosis and classification require integration of histologic, immunophenotypic, clinical, molecular and genomic parameters. Furthermore, there is rapid evolution of molecular prognostic factors and therapeutic markers that have clinical impact and challenge pathologists. This interactive microscopy course, supplemented by lectures, highlights the practical aspects of important changes impacting the diagnostic approach to indolent and aggressive B cell lymphomas, Hodgkin lymphoma and T cell lymphoma.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:

  • Improve ability to diagnose indolent and aggressive B cell lymphomas, Hodgkin Lymphoma and T cell lymphoma 
  • Refine skills related to the use of immunohistochemical and molecular studies to identify clinically relevant subtypes of indolent and aggressive B cell lymphomas and T cell lymphomas 
  • Enhance ability to distinguish diffuse large B cell lymphomas (DLBCLs) from other aggressive B cell lymphomas 
  • Better distinguish Hodgkin lymphoma from other B or T cell lymphomas 
  • Enhance capability of evaluating lymphomas for clinically relevant targeted therapy  

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 15.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Beginning in 2021, the American Board of Pathology (ABPath) will no longer require Self-Assessment Modules (SAMs) for Part II Lifelong Learning of the Continuing Certification program. For additional information, visit the ABPath website.

Disclosures

Buy the entire Practical Updates in Lymphoma course and get a great discount!
Not A Member? Click Here